Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Current Hematology Reports|July 13, 2005
Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cellsBoro DropulicHuman Gene Therapy|June 17, 2006
Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndromeBoro Dropulic, Carl H JuneMolecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replicationBrian M Davis, Laurent Humeau, Boro DropulicPDA Journal of Pharmaceutical Science and Technology|April 20, 2011
Lentiviral vector-mediated genetic modification of cell substrates for the manufacture of proteins and other biologicsLajos Baranyi, Andre Roy, Heather D Embree, et al.Journal of Virology|June 15, 2004
Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistanceXiaobin Lu, Qiao Yu, Gwendolyn K Binder, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2021
Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19+ Raji lymphoma in preclinical modelsBrian Webster, Ying Xiong, Peirong Hu, et al.Autophagy|May 2, 2013
Harnessing autophagy for cell fate control gene therapyTania C Felizardo, Jason Foley, Kevin Steed, et al.Molecular Therapy. Nucleic Acids|September 10, 2018
Stable Transcriptional Repression and Parasitism of HIV-1Surya Shrivastava, Paige Charlins, Amanda Ackley, et al.Cytotherapy|December 31, 2017
Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical centerFenlu Zhu, Nirav Shah, Huiqing Xu, et al.Journal for Immunotherapy of Cancer|May 19, 2017
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell linesDina Schneider, Ying Xiong, Darong Wu, et al.Pageof 5